Preventing Smoking Relapse After Total Joint Replacement Surgery
NCT ID: NCT03673228
Last Updated: 2021-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2019-01-15
2021-01-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
Participants randomized to the Intervention Arm will receive counseling that includes:
* A Visit prior to discharge
* Follow up calls after discharge
* Text Messaging Support
* Caregiver Support
Comprehensive Relapse Prevention Intervention
This intervention consists of 4 components:
1. Visit Prior to Discharge: counselor from research team will visit patient at hospital bedside to provide counseling
2. Follow up calls after discharge: 6 proactive counseling calls and initiate unlimited reactive calls to their counselor, at days 1,3,7,14,30,an 60 days after hospital visit
3. Text messaging support: patients will be registered in NCI's Smokefree TXT while in the hospital and will receive multiple daily messages, designed for someone who has already quit
4. Caregiver support: 10 minute training session to the caregiver on how to help patient prevent relapse by increasing self efficacy, maintaining motivation and dealing with high risk situations
Nicotine Replacement Therapy (NRT)
Patients in both arms will be encouraged to receive NRT
Standard treatment
Patients will receive current usual care.
Standard Treatment Counseling
Participants will receive two 10 minute counseling calls from the staff of the preoperative counseling program during the first month after the hospital discharge
Nicotine Replacement Therapy (NRT)
Patients in both arms will be encouraged to receive NRT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Comprehensive Relapse Prevention Intervention
This intervention consists of 4 components:
1. Visit Prior to Discharge: counselor from research team will visit patient at hospital bedside to provide counseling
2. Follow up calls after discharge: 6 proactive counseling calls and initiate unlimited reactive calls to their counselor, at days 1,3,7,14,30,an 60 days after hospital visit
3. Text messaging support: patients will be registered in NCI's Smokefree TXT while in the hospital and will receive multiple daily messages, designed for someone who has already quit
4. Caregiver support: 10 minute training session to the caregiver on how to help patient prevent relapse by increasing self efficacy, maintaining motivation and dealing with high risk situations
Standard Treatment Counseling
Participants will receive two 10 minute counseling calls from the staff of the preoperative counseling program during the first month after the hospital discharge
Nicotine Replacement Therapy (NRT)
Patients in both arms will be encouraged to receive NRT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Received preoperative smoking cessation counseling through Orthopedic Surgery Quit Smoking Program
* Undergoing elective knee or hip arthroplasty surgery
* Have not smoked any cigarettes in the week prior to admission and carbon monoxide 4 ppm46,47
* Have a cell phone (for text messaging)
* Provide informed consent in English
Caregiver participants:
* Age ≥ 18 years
* Be a caregiver of the patient participant
* Provide informed consent in English
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Sherman, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-00723
Identifier Type: -
Identifier Source: org_study_id